✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals
Market Cap
₹1,21,592 Cr.
P/E
23.06
  • Cipla
  • Dr. Reddy's Lab
  • Torrent Pharma
  • TJI Pharma
FAQs on Cipla Ltd. Shareprice

Cipla has given lower returns compared to its competitors.
Cipla has grown at ~24.01% over the last 2yrs while peers have grown at a median rate of 31.05%

Cipla is not expensive.
Latest PE of Cipla is 23.06, while 3 year average PE is 29.79.
Also latest EV/EBITDA of Cipla is 16.96 while 3yr average is 17.52.

Growth Table
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Balance Sheet
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Cash Flow
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Quarterly Results
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Cipla Ltd. Financials

Balance sheet of Cipla is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Cipla is increasing.
Latest net debt of Cipla is -₹707.74 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹1,371.15 Crs.

Yes, profit is increasing.
The profit of Cipla is ₹5,291 Crs for TTM, ₹4,122 Crs for Mar 2024 and ₹2,802 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Cipla latest dividend payout ratio is 25.47% and 3yr average dividend payout ratio is 21.99%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech